Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice

Cancer Cell

Volumn 4, Issue 1, 2003, Pages 55-65

  Ishida, Daisuke ^a   Kometani, Kohei ^a   Yang, Hailin ^a,g   Kakugawa, Kiyokazu ^a   Masuda, Kyoko ^a   Iwai, Kazuhiro ^a,h   Suzuki, Misao ^d   Itohara, Shigeyoshi ^e   Nakahata, Tatsutoshi ^b   Hiai, Hiroshi ^c   Kawamoto, Hiroshi ^f   Hattori, Masakazu ^a   Minato, Nagahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^f RIKEN   (Japan)

^g HARVARD MEDICAL SCHOOL   (United States)

^h Osaka City University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; RAP PROTEIN;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; GENETIC DISORDER; HEMATOPOIETIC STEM CELL; HUMAN; IN VIVO STUDY; LEUKEMOGENESIS; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SOMATIC CELL GENETICS; STEM CELL;

ANIMALIA;

EID: 10744228326     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00163-6     Document Type: Article

References (57)

1. Arai A., Nosaka Y., Kanda E., Yamamoto K., Miyasaka N., Miura O. Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion. J. Biol. Chem. 276:2001;10453-10462.
2. Arroyo A.G., Yang J.T., Rayburn H., Hynes R.O. Alpha4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity. 11:1999;555-566.
3. Birnbaum R.A., O'Marcaigh A., Wardak Z., Zhang Y.Y., Dranoff G., Jacks T., Clapp D.W., Shannon K.M. NF1 and GM-CSF interact in myeloid leukemogenesis. Mol. Cell. 5:2000;189-195.
4. Bollag G., Clapp D.W., Shih S., Adler F., Zhang Y.Y., Thompson P., Lange B.J., Freedman M.H., McCormick F., Jacks T., Shannon K. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat. Genet. 12:1996;144-148.
5. Bos J.L. Ras oncogenes in hematopoietic malignancies. Hematol. Pathol. 2:1988;55-63.
6. Bos J.L., de Rooij J., Reedquist K.A. Rap1 signaling. adhering to new models Nat. Rev. Mol. Cell Biol. 2:2001;369-377.
7. Bouschet T., Perez V., Fernandez C., Bockaert J., Eychene A., Journot L. Stimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C, and protein kinase A in neuronal cells. J. Biol. Chem. 278:2003;4778-4785.
8. Brown D., Kogan S., Lagasse E., Weissman I., Alcalay M., Pelicci P.G., Atwater S., Bishop J.M. A PMLRARα transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 94:1997;2551-2556.
9. Caron E., Self A.J., Hall A. The GTPase Rap1 controls functional activation of macrophage integrin αMβ2 by LPS and other inflammatory mediators. Curr. Biol. 10:2000;974-978.
10. Cook S.J., Rubinfeld B., Albert I., McCormick F. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:1993;3475-3485.
11. Corral J., Lavenir I., Impey H., Warren A.J., Forster A., Larson T.A., Bell S., McKenzie A.N., King G., Rabbitts T.H. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice. a method to create fusion oncogenes Cell. 85:1996;853-861.
12. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 396:1998;474-477.
13. Dupuy A.J., Morgan K., von Lintig F.C., Shen H., Acar H., Hasz D.E., Jenkins N.A., Copeland N.G., Boss G.R., Largaespada D.A. Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia. J. Biol. Chem. 276:2001;11804-11811.
14. Faderl S., Talpaz M., Estrov Z., O'Brien S., Kurzrock R., Kantarjian H.M. The biology of chronic myeloid leukemia. N. Engl. J. Med. 341:1999;164-172.
15. Gao Q., Srinivasan S., Boyer S.N., Wazer D.E., Band V. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19:1999;733-744.
16. Gao Q., Singh L., Kumar A., Srinivasan S., Wazer D.E., Band V. Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J. Virol. 75:2001;4459-4466.
17. Gao Q., Kumar A., Singh L., Huibregtse J.M., Beaudenon S., Srinivasan S., Wazer D.E., Band H., Band V. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res. 62:2002;3315-3321.
18. Gotoh T., Hattori S., Nakamura S., Kitayama H., Noda M., Takai Y., Kaibuchi K., Matsui H., Hatase O., Takahashi H.et al. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15:1995;6746-6753.
19. Hattori M., Tsukamoto N., Nur-E-Kamal M.S., Rubinfeld B., Iwai K., Kubota H., Maruta H., Minato N. Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol. Cell. Biol. 15:1995;552-560.
20. Hawley R.G., Lieu F.H., Fong A.Z., Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:1994;136-138.
21. Heaney M.L., Golde D.W. Myelodysplasia. N. Engl. J. Med. 340:1999;1649-1660.
22. Higuchi M., O'Brien D., Kumaravelu P., Lenny N., Yeoh E.J., Downing J.R. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 1:2002;63-74.
23. Hu C.D., Kariya K., Kotani G., Shirouzu M., Yokoyama S., Kataoka T. Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1. J. Biol. Chem. 272:1997;11702-11705.
24. Ishida D., Yang H., Masuda K., Uesugi K., Kawamoto H., Hattori M., Minato N. Antigen-driven T cell anergy and defective memory T cell response via deregulated Rap1 activation in SPA-1-deficient mice. Proc. Natl. Acad. Sci. USA. in press:2003.
25. Kabarowski J.H., Witte O.N. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia. Stem Cells. 18:2000;399-408.
26. Katagiri K., Hattori M., Minato N., Irie S., Takatsu K., Kinashi T. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol. Cell. Biol. 20:2000;1956-1969.
27. Katagiri K., Hattori M., Minato N., Kinashi T. Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses. Mol. Cell. Biol. 22:2002;1001-1015.
28. Kawasaki H., Springett G.M., Toki S., Canales J.J., Harlan P., Blumenstiel J.P., Chen E.J., Bany I.A., Mochizuki N., Ashbacher A.et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc. Natl. Acad. Sci. USA. 95:1998;13278-13283.
29. Kitayama H., Sugimoto Y., Matsuzaki T., Ikawa Y., Noda M. A ras-related gene with transformation suppressor activity. Cell. 56:1989;77-84.
30. Kolb H.J., Schattenberg A., Goldman J.M., Hertenstein B., Jacobsen N., Arcese W., Ljungman P., Ferrant A., Verdonck L., Niederwieser D.et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 86:1995;2041-2050.
31. Kouides P.A., Bennett J.M. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin. Hematol. 33:1996;95-110.
32. Kurachi H., Wada Y., Tsukamoto N., Maeda M., Kubota H., Hattori M., Iwai K., Minato N. Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap. 1GAP(gene product. J. Biol. Chem. 272):1997;28081-28088.
33. Largaespada D.A., Brannan C.I., Jenkins N.A., Copeland N.G. NF1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat. Genet. 12:1996;137-143.
34. Mikula M., Schreiber M., Husak Z., Kucerova L., Ruth J., Wieser R., Zatloukal K., Beug H., Wagner E.F., Baccarini M. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20:2001;1952-1962.
35. Miyake K., Weissman I.L., Greenberger J.S., Kincade P.W. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J. Exp. Med. 173:1991;599-607.
36. Mochizuki N., Ohba Y., Kiyokawa E., Kurata T., Murakami T., Ozaki T., Kitabatake A., Nagashima K., Matsuda M. Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with Gαi. Nature. 400:1999;891-894.
37. Nishi N., Nakahata T., Koike K., Takagi M., Naganuma K., Akabane T. Induction of mixed erythroid-megakaryocyte colonies and bipotential blast cell colonies by recombinant human erythropoietin in serum-free culture. Blood. 76:1990;1330-1335.
38. Ohba Y., Kurokawa K., Matsuda M. Mechanism of the spatio-temporal regulation of Ras and Rap1. EMBO J. 22:2003;859-869.
39. Pak D.T., Yang S., Rudolph-Correia S., Kim E., Sheng M. Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron. 31:2001;289-303.
40. Passegue E., Jochum W., Schorpp-Kistner M., Mohle-Steinlein U., Wagner E.F. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell. 104:2001;21-32.
41. Pear W.S., Miller J.P., Xu L., Pui J.C., Soffer B., Quackenbush R.C., Pendergast A.M., Bronson R., Aster J.C., Scott M.L., Baltimore D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 92:1998;3780-3792.
42. Prasad R., Gu Y., Alder H., Nakamura T., Canaani O., Saito H., Huebner K., Gale R.P., Nowell P.C., Kuriyama K.et al. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res. 53:1993;5624-5628.
43. Reedquist K.A., Ross E., Koop E.A., Wolthuis R.M., Zwartkruis F.J., van Kooyk Y., Salmon M., Buckley C.D., Bos J.L. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148:2000;1151-1158.
44. Rubinfeld B., Munemitsu S., Clark R., Conroy L., Watt K., Crosier W.J., McCormick F., Polakis P. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell. 65:1991;1033-1042.
45. Sebzda E., Bracke M., Tugal T., Hog N., Cantrel D.A. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat. Immunol. 3:2002;251-258.
46. Shimonaka M., Katagiri K., Nakayam T., Fujita N., Tsuruo T., Yoshie O., Kinash T. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J. Cell Biol. 161:2003;417-427.
47. Su L., Hattori M., Moriyama M., Murata N., Harazaki M., Kaibuchi K., Minato N. AF-6 controls integrin-mediated cell adhesion by regulating Rap1 activation through the specific recruitment of Rap1GTP and SPA-1. J. Biol. Chem. 278:2003;15232-15238.
48. Tsukamoto N., Hattori M., Yang H., Bos J.L., Minato N. Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J. Biol. Chem. 274:1999;18463-18469.
49. Uemura N., Griffin J.D. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration. J. Biol. Chem. 274:1999;37525-37532.
50. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., Stork P.J. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
51. Wada Y., Kubota H., Maeda M., Taniwaki M., Hattori M., Imamura S., Iwai K., Minato N. Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human. Genomics. 39:1997;66-73.
52. Wary K.K., Mainiero F., Isakoff S.J., Marcantonio E.E., Giancotti F.G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell. 87:1996;733-743.
53. Wienecke R., Konig A., DeClue J.E. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap. 1GAP(activity. J. Biol. Chem. 270):1995;16409-16414.
54. Wolff L. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. Biochem. Biophys. Acta. 1332:1997;F67-F104.
55. Wong K.F. 11q13 is a cytogenetically promiscuous site in hematologic malignancies. Cancer Genet. Cytogenet. 113:1999;93-95.
56. Yajnik V., Paulding C., Sordella R., McClatchey A.I., Saito M., Wahrer D.C., Reynolds P., Bell D.W., Lake R., van den Heuvel S.et al. DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell. 112:2003;673-684.
57. York R.D., Yao H., Dillon T., Ellig C.L., Eckert S.P., McCleskey E.W., Stork P.J. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 392:1998;622-626.